Mitoxantrone bulk supplier for pharma manufacturers

Mitoxantrone 2 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/mL

Reference Brands: Novantrone (USA)

Mitoxantrone (brand name Novantrone® and generics) is an antineoplastic (chemotherapy) medication used to treat certain cancers like acute nonlymphocytic leukemia (ANLL), advanced prostate cancer, and selected multiple sclerosis (MS) cases by slowing down abnormal cell growth and suppressing an overactive immune system. It is delivered as an intravenous infusion in a clinical setting.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Mitoxantrone hydrochloride is an antineoplastic chemotherapy medication widely used in Oncology Cancer Care for treating various malignant conditions. It is most commonly prescribed for acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe cases of multiple sclerosis where other therapies have not been effective. Mitoxantrone works by binding to DNA and inhibiting topoisomerase II, an essential enzyme involved in DNA replication and repair. This action disrupts the growth and division of rapidly multiplying cancer cells, ultimately leading to their destruction. The drug is administered strictly by intravenous infusion under medical supervision, ensuring controlled dosing and monitoring for potential side effects. In oncology settings, mitoxantrone is often used in combination with other chemotherapeutic agents to increase treatment effectiveness. It is known for its deep blue coloration and is typically supplied as a 2 mg/mL injection solution in single-dose or multi-dose vials. While effective, mitoxantrone requires careful monitoring due to the risk of cardiotoxicity, bone marrow suppression, and cumulative dose limitations. Despite these considerations, it remains an important treatment option in modern cancer therapy and is widely used in many global treatment protocols.

Mitoxantrone — third party manufacturing & bulk supply

Mitoxantrone 2 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Mitoxantrone is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Mitoxantrone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Mitoxantrone →

Back to Listing

Frequently Asked Questions

Mitoxantrone is used to treat acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe forms of multiple sclerosis where other treatments have failed or are not suitable.

Mitoxantrone is made from a synthetic anthracenedione compound that disrupts DNA and RNA synthesis, leading to the inhibition of cancer cell growth.

The trade name most commonly associated with mitoxantrone is Novantrone.

Mitoxantrone and Novantrone have been manufactured by several pharmaceutical companies, including original brand manufacturers and multiple generic producers for hospital use.

The generic name is Mitoxantrone hydrochloride.

The primary brand name is Novantrone.

Mitoxantrone is manufactured by various licensed pharmaceutical companies across the United States, Europe, and India depending on the brand or generic supplier.